Literature DB >> 32613398

Quality of life and mortality after surgical treatment for vertebral osteomyelitis (VO): a prospective study.

Ayla Yagdiran1, Norma Jung2, Jan Siewe3,4, Christina Otto-Lambertz5, Kristina Michaela Lingscheid5, Krishnan Sircar5, Christina Samel6, Max Joseph Scheyerer5, Kourosh Zarghooni5, Peer Eysel5, Rolf Sobottke7.   

Abstract

PURPOSE: Vertebral osteomyelitis (VO) has a high mortality and leads to chronic pain and functional disability. Surgical treatment is often necessary. To date, little is known about the consequences of surgery on patient outcome. The aim of this study was to determine the quality of life (QoL) and mortality rates of surgically treated VO patients for a period of 2 years.
METHODS: Patients with VO undergoing surgical treatment in a tertiary referral hospital from 2008 to 2015 were included prospectively. Data were collected before (T0) as well as 1 year (T1) and 2 years (T2) post-surgery. Within the European Spine Tango registry, prospective patient and QoL data were collected using validated outcome scores: Oswestry Disability Index, Short Form 36/EuroQol, Visual Analog Scale, and Core Outcome Measures Index.
RESULTS: From 195 patients surgically treated for VO, QoL data were available from 136 patients at T0, 100 patients at T1, and 82 patients at T2, respectively. The 1- and 2-year mortality rates were 20% and 23%. Mainly all QoL outcome scores showed significant improvement at T1 and did not change significantly from T1 to T2.
CONCLUSION: Surgical treatment of VO patients leads to significantly improved QoL. Nevertheless, QoL levels were below those of the general population. Our results underscore that spine disability questionnaires measuring QoL are mandatory to demonstrate comprehensively the severity of this entity. Our study confirms a high mortality and points out the role of VO as a potentially life-threatening condition.
© 2020. The Author(s).

Entities:  

Keywords:  Core Outcome Measures Index (COMI); Oswestry Disability Index (ODI); Short Form 36 (SF-36); Spondylodiscitis; Visual Analogue Scale (VAS)

Year:  2020        PMID: 32613398     DOI: 10.1007/s00586-020-06519-z

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  2 in total

1.  Spondylodiscitis: Diagnosis and Treatment Options.

Authors:  Christian Herren; Norma Jung; Miguel Pishnamaz; Marianne Breuninger; Jan Siewe; Rolf Sobottke
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

2.  Current diagnosis and treatment of spondylodiscitis.

Authors:  Rolf Sobottke; Harald Seifert; Gerd Fätkenheuer; Matthias Schmidt; Axel Gossmann; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2008-03-07       Impact factor: 5.594

  2 in total
  2 in total

1.  Can we predict favourable quality of life after surgically treated vertebral osteomyelitis? Analysis of a prospective study.

Authors:  A Yagdiran; C Otto-Lambertz; B Sondermann; A Ernst; D Jochimsen; R Sobottke; J Siewe; P Eysel; N Jung
Journal:  Arch Orthop Trauma Surg       Date:  2022-03-31       Impact factor: 3.067

2.  The Burden of Vertebral Osteomyelitis-An Analysis of the Workforce before and after Treatment.

Authors:  Ayla Yagdiran; Jan Bredow; Carolyn Weber; Ghaith Mousa Basha; Peer Eysel; Julia Fischer; Norma Jung
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.